POLISCOPE
Back to feed
NewsThe GuardianMay 4, 2026United States

Supreme Court Temporarily Protects Access to Mail-Order Abortion Pill

The US Supreme Court has issued a temporary order maintaining nationwide access to the abortion medication mifepristone. This action pauses a lower court ruling that would have restricted the drug's distribution by mail while the legal challenge continues.

abortionmifepristoneUS Supreme Courtreproductive rightshealthcare regulation
Read the full story at The Guardian

Why It Matters

The order ensures that patients and providers can continue to use and prescribe via mail until at least May 11, 2024, preventing immediate changes to current abortion medication access.

Key Facts

  • The US Supreme Court issued an order temporarily blocking a lower court ruling that would have restricted mail-order access to mifepristone.
  • The order remains in effect until at least 5pm ET on 11 May 2024.
  • The Supreme Court gave the state of Louisiana until 5pm ET on Thursday to respond to the emergency appeal.
  • The underlying lower court ruling came from a three-judge panel at the fifth US circuit court of appeals in New Orleans.
  • The lower court ruling sought to prevent abortion providers from prescribing mifepristone through the mail.
  • Mifepristone is used in nearly two-thirds of pregnancy terminations in the US.
  • Mifepristone is typically taken in a two-drug regimen alongside misoprostol.
  • Danco Laboratories filed the emergency appeal to the Supreme Court on Saturday.
  • The Supreme Court previously rejected a challenge to mifepristone access in 2024.

Who's Mentioned

organizationAmerican Civil Liberties Union“Legal organization involved in reproductive rights advocacy.”personSamuel Alito“Supreme Court Justice who signed the order pausing the lower court's restriction”organizationDanco Laboratories“Manufacturer of mifepristone that filed the emergency appeal to the Supreme Cour”date11 May“Deadline for the current Supreme Court order.”organizationPlanned Parenthood Action Fund“Advocacy group commenting on the impact of the legal proceedings.”organizationFood and Drug Administration“Federal agency being sued over the regulation of mifepristone.”locationLouisiana“State government that filed the lawsuit against the FDA regarding mifepristone d”